In summary, the R206H mutation in ALK2 is common in FOP patients and results in an increased and uncontrolled pro-osteogenic Smad1/5/8 (BMP) signaling induced by activin A. The gene discussed is SMAD1; the disease is fibrodysplasia ossificans progressiva.